The New Search Paradigm: From SEO to Generative Engine Optimization (GEO) – A Strategic Briefing
Executive Summary: A Generational Shift in Digital Presence The way information is found and consumed
Insights
Perspectives for emerging life sciences leaders.
Putnam shares practical perspectives on the communications challenges that emerge as life sciences companies finance, develop, and grow. We are focused on how better positioning supports better
business conversations.
Qualified Small Business Stock (QSBS) Opportunity for Smaller Bio- and Med-Tech Companies
Qualified Small Business Stock (QSBS) refers to a special class of stock defined under Section
The Clinical Data Dilemma: Balancing Speed and Credibility in Communicating Early-Stage Life Science Clinical Results
For any early-stage bio- or med-tech company, the arrival of initial positive clinical data presents
Content Pillars
01
Investor Communications & Fundraising
02
Enterprise Narrative & Corporate Positioning
03
Clinical, Regulatory & Scientific Milestones
04
Executive Visibility & Reputation
05
Strategic Partnerships & Corporate Change
When Your Deck, Website, and CEO Are Telling Three Different Stories
Why narrative inconsistency becomes more expensive as a company begins engaging institutional investors and strategic partners.
The Communications Work That Should Happen Before a Fundraise Starts
A practical look at positioning, management alignment, investor questions, and stakeholder preparation before outreach begins.
A Clinical Milestone Is Not a Communications Strategy
How emerging companies can connect scientific progress to the larger corporate and investor story.
Looking for a perspective on a communications challenge?
Talk with Putnam about the milestone, audience, or business objective behind it.